CYLNDR reintroduces itself as CYLNDR Studios, a modern creative studio powered by design, and unveils a new look for the brand. The new Studios label and branding evokes the company's creator ethos ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

Operator: Good afternoon and welcome to the full-year and fourth quarter 2024 Financial Results Conference Call for Verb Technology Company, Inc. At this time, all participants are in a listen-only ...

The 18 best mineral sunscreens for all skin types and tones, from Heliocare to Dermalogica, all offering superior protection ...

For many people, injection needles can be scary – and the larger ones for specialized longer-term medications are far more ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...

CorMedix (NASDAQ: CRMD) Q4 2024 Earnings Call Mar 25, 2025, 8:30 a.m. ET Good day, and welcome to the CorMedix Inc.

Braun Medical Inc. of Bethlehem, a manufacturer of infusion therapy and pain management, has announced the launch of its new ...